Jeong-nak Moon
Kyung Hee University · Medicine
About the Lab
Professor Jeong-nak Moon's research lab focuses on gastrointestinal diseases, particularly inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease, with an emphasis on biomarkers, disease progression, and healthcare economics. The lab investigates clinical and molecular mechanisms underlying IBD, including inflammatory markers like NLR and PLR, and explores the role of key signaling molecules such as TGF-β1 and XAF1 in colorectal cancer progression. Additionally, the lab evaluates therapeutic interventions, including bowel preparation agents and psychosocial management strategies, to improve patient outcomes. Their work leverages large-scale national health databases to analyze long-term trends in IBD-related healthcare costs and treatment efficacy.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15BACKGROUND/AIMS: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) can serve as biomarkers for diagnosing and assessing disease activity in ulcerative colitis (UC). We investigated their clinical significance in UC. METHODS: We analyzed 48 patients with UC who underwent measurement of fecal calprotectin (FC) and endoscopy and 96 age- and sex-matched healthy controls. NLR and PLR were compared between the patients and healthy controls. The endoscopic activity was divided
Clarithromycin resistance and female gender are factors affecting H. pylori eradication failure in patients with chronic gastritis.
<b>Introduction:</b> We explored the long-term evolution of direct healthcare costs for inflammatory bowel diseases (IBD) using a population-level database in a country with an escalating burden of IBD. <b>Methods:</b> We searched the database of the Korean National Health Insurance Claims, which covers more than 97% of the South Korean population. An IBD diagnosis was defined as the combination of a billing code for Crohn's disease (CD: K50.xx) or ulcerative colitis (UC: K51.xx) and at least on
BACKGROUND AND AIM: PBK-1701TC is a novel sulfate tablet-based that contains 320 mg of simethicone and delivers 90% of the salt and water delivered by oral sulfate solution (OSS) preparation. This study evaluated the efficacy, safety, and tolerability of PBK-1701TC compared with OSS in bowel preparation for colonoscopy. METHODS: undergoing colonoscopy at five university hospitals in Korea. The primary efficacy endpoint was successful bowel-cleansing rate, defined as Harefield Cleansing Scale gra
Psychosocial screening and timely interventions should be incorporated into the initial care of patients newly diagnosed with UC.
Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine that functions as a growth suppressor in normal epithelial cells and early stage tumors, but acts as a tumor promoter during malignant progression. However, the molecular basis underlying the conversion of TGF‑β1 function remains largely undefined. X‑linked inhibitor of apoptosis‑associated factor 1 (XAF1) is a pro‑apoptotic tumor suppressor that frequently displays epigenetic inactivation in various types of human malignancies
Background/Aims: Our study aims to characterize esophageal motor function; evaluate the relationships among esophagogastroduodenoscopy (EGD), high-resolution manometry (HRM), and 24-hour esophageal multichannel intraluminal impedance monitoring combined with pH-metry (MII-pH); and elucidate the determinants of esophageal symptom perception in South Koreans with systemic sclerosis (SSc). Methods: We reviewed prospectively collected HRM (n = 46), EGD (n = 41), and MII-pH (n = 37) data from 46 cons
Objectives: Tegoprazan, a novel potassium-competitive acid blocker with rapid and effective antisecretory activity, was approved for the treatment of <i>Helicobacter pylori</i> infections in Korea in March 2020. However, real-world data regarding tegoprazan-based therapies are scarce. We compared the efficacies of tegoprazan- and lansoprazole-based triple therapies (TTs).Methods: Between March 2020 and February 2023, this study enrolled patients diagnosed with <i>H. pylori</
Background: A simple classification for the relevance of lesions (P0, P1, and P2; no bleeding potential, less likely to bleed, and more likely to bleed, respectively) based on capsule endoscopy (CE) findings has been used. This study aimed at investigating rebleeding rates and predictive factors of P0 and P1 lesions after obtaining negative findings in both, CE and computed tomography (CT), for patients with obscure gastrointestinal bleeding (OGIB). Methods: Among 193 patients resulted in negati
Abstract Background and Aim Despite the frequent loss of Ras association domain family 1 isoform A (RASSF1A) expression in various cancers, the precise mechanism underlying its tumor‐suppressive effect is not fully understood. To elucidate the growth‐inhibitory role for RASSF1A in colorectal tumorigenesis, this study investigated the RASSF1A regulation of the p53‐p21 WAF1 pathway. Methods Ras association domain family 1 isoform A effect on cellular growth was tested in three human colon cancer c
BACKGROUND: Effective bowel cleansing is essential for a successful colonoscopy. Laxatives, such as polyethylene glycol, are commonly used for bowel preparation. Vomiting is a frequent complication during bowel preparation, and forceful vomiting can potentially lead to esophageal perforation, as reported in several previous cases. However, pharyngeal perforation during bowel preparation has not been previously documented. Here, we present a case of pharyngeal perforation induced by forceful vomi
BACKGROUND: Few large-scale studies exist on within-country variations in the incidence, diagnosis, and mortality of small intestine malignancies. This study examined the epidemiological trends and outcomes of these cancers in South Korea. METHODS: We analyzed National Health Insurance Service claims data from 2005 to 2022 to identify newly diagnosed small intestine malignancies (ICD-10 code C17) and evaluated treatment modalities and diagnostic test usage. Kaplan-Meier curves and Cox proportion
Background: REACH-B is a simple scoring system to predict HCC risk in non-cirrhotic patients with CHB. It is unknown whether the model can accurately predict HCC risk in patients under long-term antiviral therapy. This study aimed to validate modified REACH-B model to predict HCC risk in patients receiving entecavir. Methods: From 2007 to 2013, total 136 naive patients with non-cirrhotic CHB who had been treated for more than 6 months were retrospectively collected.Two-year HCC risk was calculat
Research Areas
Dive deeper into Jeong-nak Moon's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.